Initial Therapeutics
Initial Therapeutics discovers small molecule drugs targeting RNA for neurological and rare diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $75M
About
Initial Therapeutics discovers small molecule drugs targeting RNA for neurological and rare diseases.
RNA TherapeuticsNeuroscienceRare Disease
Funding History
1Total raised:$75M
Venture$75M